News | February 03, 2011

Washington University First to Incorporate Real-Time, Automated Gating

February 3, 2011 – The Siteman Cancer Center at the Washington University School of Medicine in St. Louis is the first facility in the world to equip their Calypso System with Dynamic Edge Gating technology. The system, from Calypso Medical Technologies, automates the response to organ motion by sending signals to the linear accelerator to disable or re-enable the radiation beam during treatment based on the location of the tumor.

The safeguard from unintended radiation may lead to a further decrease in the side effects associated with prostate radiotherapy such as bowel and bladder incontinence and sexual dysfunction.

“Since Calypso’s gating solution uses the actual tumor target as a reference point, the resulting signal sent to the linear accelerator about when to hold or turn the beam on is accurate,” said Lakshmi Santanam, Ph.D., assistant professor, department of radiation oncology at Washington University School of Medicine. “With this enhanced capability to automatically manage tumor motion, we’ll have more confidence that our radiation delivery is on target and that adjacent healthy tissue is not compromised. We are very pleased to have this technology available to help guide our daily patient treatment sessions.”

The system, with its GPS for the Body technology, utilizes miniature implanted Beacon transponders to provide precise, continuous information on the location of the tumor during external beam radiation therapy. Dynamic Edge Gating technology allows therapists to set motion thresholds that automatically signal radiation delivery to be stopped each time the targeted tissue moves outside the preset threshold. The technology was recently cleared by the U.S. Food and Drug Administration (FDA).

Previously, the system relied upon the therapist to manually intervene and halt radiation delivery when healthy tissue was in danger of receiving unintended radiation. The automation of this function eliminates operator subjectivity, which results in a more uniform approach to radiation delivery.

“Calypso’s gating technology helps to control the inter-therapist variability inherent in multiple session radiation therapy by automating a previously manual function and basing beam-hold interventions on objective data, specific for each patient,” said Edward Vertatschitsch, president and CEO of Calypso Medical. “Moreover, the added safeguard of Dynamic Edge Gating against unintended radiation will provide peace of mind for both physicians and patients that the prescribed dose of radiation is delivered to the intended target area.”

The company’s electromagnetic technology is the only non-ionizing guidance solution to keep the treatment precisely focused on the target without adding unnecessary radiation.

For more information:

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init